| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | bitter taste receptor activity | TAS2R14 TAS2R33 TAS2R36 TAS2R45 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 | 2.73e-19 | 27 | 98 | 11 | GO:0033038 |
| GeneOntologyMolecularFunction | taste receptor activity | TAS2R14 TAS2R33 TAS2R36 TAS2R45 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 | 3.95e-18 | 33 | 98 | 11 | GO:0008527 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC12A6 CACNA1F SLC36A4 SLC2A7 SLC22A11 SLC19A2 FLVCR2 OTOP3 SLC13A2 SLC1A6 SLC22A7 SLC39A8 ABCB1 ABCB4 ITPR3 SLC22A9 P2RX7 NALCN SLC15A1 SLC15A2 SLC26A7 SCN1A SCN4A SCN7A SCN8A SCN10A SLC47A1 ATP13A3 SLC25A29 SLC41A1 ATP2B1 SLC7A10 ATP2B4 | 5.94e-17 | 1180 | 98 | 33 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | SLC12A6 CACNA1F SLC36A4 SLC2A7 SLC22A11 SLC19A2 FLVCR2 OTOP3 SLC13A2 SLC1A6 SLC22A7 SLC39A8 ABCB1 ABCB4 ITPR3 SLC22A9 P2RX7 NALCN SLC15A1 SLC15A2 SLC26A7 SCN1A SCN4A SCN7A SCN8A SCN10A TMEM30A SLC47A1 ATP13A3 SLC25A29 SLC41A1 ATP2B1 SLC7A10 ATP2B4 | 1.01e-16 | 1289 | 98 | 34 | GO:0005215 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | VN1R2 GALR1 OR1S1 FPR1 OR4C45 ADGRV1 OR51E2 GHRHR OR2B11 CELSR1 TAS2R14 OR2A12 GPR142 TAS2R33 TAS2R36 MTNR1A OPN5 TAS2R45 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 GPR176 CX3CR1 | 9.59e-15 | 884 | 98 | 27 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | VN1R2 GALR1 OR1S1 FPR1 OR4C45 ADGRV1 PLXNB2 OR51E2 GHRHR OR2B11 CELSR1 TAS2R14 OR2A12 P2RX7 GPR142 TAS2R33 TAS2R36 SCN7A MTNR1A OPN5 TAS2R45 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 GPR176 CX3CR1 | 9.91e-13 | 1353 | 98 | 30 | GO:0004888 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC12A6 CACNA1F OTOP3 SLC13A2 SLC1A6 SLC39A8 ITPR3 P2RX7 NALCN SLC15A1 SLC15A2 SCN1A SCN4A SCN7A SCN8A SCN10A SLC47A1 ATP13A3 SLC41A1 ATP2B1 ATP2B4 | 7.66e-12 | 664 | 98 | 21 | GO:0008324 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC12A6 SLC36A4 SLC22A11 SLC13A2 SLC1A6 SLC22A7 SLC39A8 ABCB1 ABCB4 SLC22A9 SLC15A1 SLC15A2 SLC26A7 SLC47A1 ATP13A3 SLC41A1 ATP2B1 ATP2B4 | 1.65e-11 | 477 | 98 | 18 | GO:0022804 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC12A6 CACNA1F OTOP3 SLC13A2 SLC1A6 SLC39A8 ITPR3 P2RX7 NALCN SLC15A1 SLC15A2 SLC26A7 SCN1A SCN4A SCN7A SCN8A SCN10A SLC47A1 ATP13A3 SLC41A1 ATP2B1 ATP2B4 | 2.89e-11 | 793 | 98 | 22 | GO:0015075 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC12A6 CACNA1F SLC22A11 OTOP3 SLC13A2 SLC1A6 SLC39A8 ITPR3 NALCN SLC15A1 SLC15A2 SLC26A7 SCN1A SCN4A SCN7A SCN8A SCN10A SLC47A1 SLC41A1 ATP2B1 ATP2B4 | 9.00e-11 | 758 | 98 | 21 | GO:0015318 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC12A6 CACNA1F OTOP3 SLC13A2 SLC1A6 SLC39A8 ITPR3 NALCN SLC15A1 SLC15A2 SCN1A SCN4A SCN7A SCN8A SCN10A SLC47A1 SLC41A1 ATP2B1 ATP2B4 | 1.81e-10 | 627 | 98 | 19 | GO:0022890 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC36A4 SLC22A11 SLC19A2 SLC13A2 SLC1A6 SLC22A7 SLC39A8 ABCB1 SLC22A9 SLC26A7 SLC47A1 SLC25A29 SLC7A10 | 1.98e-09 | 293 | 98 | 13 | GO:0008514 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC12A6 SLC36A4 SLC22A11 SLC13A2 SLC1A6 SLC22A7 SLC39A8 SLC22A9 SLC15A1 SLC15A2 SLC26A7 SLC47A1 SLC41A1 | 2.24e-09 | 296 | 98 | 13 | GO:0015291 |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 2.55e-09 | 26 | 98 | 6 | GO:0005248 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | SLC36A4 SLC19A2 SLC13A2 SLC1A6 SLC22A7 ABCB1 SLC22A9 SLC26A7 SLC47A1 SLC25A29 SLC7A10 | 5.80e-09 | 207 | 98 | 11 | GO:0046943 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | SLC36A4 SLC19A2 SLC13A2 SLC1A6 SLC22A7 ABCB1 SLC22A9 SLC26A7 SLC47A1 SLC25A29 SLC7A10 | 6.10e-09 | 208 | 98 | 11 | GO:0005342 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC12A6 CACNA1F SLC13A2 SLC1A6 SLC39A8 ITPR3 NALCN SCN1A SCN4A SCN7A SCN8A SCN10A SLC41A1 ATP2B1 ATP2B4 | 7.99e-09 | 465 | 98 | 15 | GO:0046873 |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | SLC12A6 SLC13A2 SLC1A6 SLC39A8 SLC15A1 SLC15A2 SLC26A7 SLC47A1 ATP13A3 SLC41A1 ATP2B1 ATP2B4 | 2.83e-08 | 301 | 98 | 12 | GO:0022853 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.64e-07 | 171 | 98 | 9 | GO:0015081 | |
| GeneOntologyMolecularFunction | sodium channel activity | 2.03e-07 | 52 | 98 | 6 | GO:0005272 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 3.33e-06 | 83 | 98 | 6 | GO:0015101 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNA1F OTOP3 ITPR3 P2RX7 NALCN SCN1A SCN4A SCN7A SCN8A SCN10A | 7.20e-06 | 343 | 98 | 10 | GO:0005261 |
| GeneOntologyMolecularFunction | symporter activity | 9.17e-06 | 150 | 98 | 7 | GO:0015293 | |
| GeneOntologyMolecularFunction | channel activity | SLC12A6 CACNA1F OTOP3 ITPR3 P2RX7 NALCN SLC26A7 SCN1A SCN4A SCN7A SCN8A SCN10A | 1.00e-05 | 525 | 98 | 12 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | SLC12A6 CACNA1F OTOP3 ITPR3 P2RX7 NALCN SLC26A7 SCN1A SCN4A SCN7A SCN8A SCN10A | 1.02e-05 | 526 | 98 | 12 | GO:0022803 |
| GeneOntologyMolecularFunction | dicarboxylic acid transmembrane transporter activity | 1.55e-05 | 31 | 98 | 4 | GO:0005310 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA1F OTOP3 ITPR3 P2RX7 NALCN SLC26A7 SCN1A SCN4A SCN7A SCN8A SCN10A | 1.56e-05 | 459 | 98 | 11 | GO:0005216 |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 2.59e-05 | 71 | 98 | 5 | GO:0015179 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 2.66e-05 | 119 | 98 | 6 | GO:0015294 | |
| GeneOntologyMolecularFunction | amide transmembrane transporter activity | 5.29e-05 | 42 | 98 | 4 | GO:0042887 | |
| GeneOntologyMolecularFunction | ceramide floppase activity | 7.13e-05 | 3 | 98 | 2 | GO:0099038 | |
| GeneOntologyMolecularFunction | sodium-independent organic anion transmembrane transporter activity | 8.87e-05 | 18 | 98 | 3 | GO:0015347 | |
| GeneOntologyMolecularFunction | putrescine transmembrane transporter activity | 1.42e-04 | 4 | 98 | 2 | GO:0015489 | |
| GeneOntologyMolecularFunction | peptide:proton symporter activity | 1.42e-04 | 4 | 98 | 2 | GO:0015333 | |
| GeneOntologyMolecularFunction | sphingolipid floppase activity | 1.42e-04 | 4 | 98 | 2 | GO:0046623 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 1.68e-04 | 105 | 98 | 5 | GO:0015171 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 2.01e-04 | 109 | 98 | 5 | GO:0042626 | |
| GeneOntologyMolecularFunction | dipeptide transmembrane transporter activity | 2.36e-04 | 5 | 98 | 2 | GO:0071916 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 3.44e-04 | 28 | 98 | 3 | GO:0140326 | |
| GeneOntologyMolecularFunction | alpha-ketoglutarate transmembrane transporter activity | 3.53e-04 | 6 | 98 | 2 | GO:0015139 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 4.12e-04 | 196 | 98 | 6 | GO:0005319 | |
| GeneOntologyMolecularFunction | thiamine transmembrane transporter activity | 4.93e-04 | 7 | 98 | 2 | GO:0015234 | |
| GeneOntologyMolecularFunction | phosphatidylcholine floppase activity | 6.55e-04 | 8 | 98 | 2 | GO:0090554 | |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 7.28e-04 | 36 | 98 | 3 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 7.28e-04 | 36 | 98 | 3 | GO:0015662 | |
| GeneOntologyMolecularFunction | tripeptide transmembrane transporter activity | 8.39e-04 | 9 | 98 | 2 | GO:0042937 | |
| GeneOntologyMolecularFunction | peptide transmembrane transporter activity | 8.39e-04 | 9 | 98 | 2 | GO:1904680 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 1.07e-03 | 41 | 98 | 3 | GO:0015175 | |
| GeneOntologyMolecularFunction | polyamine transmembrane transporter activity | 1.27e-03 | 11 | 98 | 2 | GO:0015203 | |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 1.27e-03 | 11 | 98 | 2 | GO:0005388 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 1.79e-03 | 49 | 98 | 3 | GO:0140359 | |
| GeneOntologyMolecularFunction | L-arginine transmembrane transporter activity | 1.80e-03 | 13 | 98 | 2 | GO:0061459 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 1.85e-03 | 178 | 98 | 5 | GO:0015399 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 2.01e-03 | 51 | 98 | 3 | GO:0140303 | |
| GeneOntologyMolecularFunction | azole transmembrane transporter activity | 2.09e-03 | 14 | 98 | 2 | GO:1901474 | |
| GeneOntologyMolecularFunction | prostaglandin transmembrane transporter activity | 2.09e-03 | 14 | 98 | 2 | GO:0015132 | |
| GeneOntologyMolecularFunction | sodium ion binding | 2.09e-03 | 14 | 98 | 2 | GO:0031402 | |
| GeneOntologyMolecularFunction | C4-dicarboxylate transmembrane transporter activity | 2.40e-03 | 15 | 98 | 2 | GO:0015556 | |
| GeneOntologyMolecularFunction | icosanoid transmembrane transporter activity | 2.40e-03 | 15 | 98 | 2 | GO:0071714 | |
| GeneOntologyMolecularFunction | oligopeptide transmembrane transporter activity | 2.74e-03 | 16 | 98 | 2 | GO:0035673 | |
| GeneOntologyMolecularFunction | floppase activity | 2.74e-03 | 16 | 98 | 2 | GO:0140328 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 3.09e-03 | 17 | 98 | 2 | GO:0099508 | |
| GeneOntologyMolecularFunction | flippase activity | 3.09e-03 | 17 | 98 | 2 | GO:0140327 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 3.36e-03 | 61 | 98 | 3 | GO:1901682 | |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 3.52e-03 | 62 | 98 | 3 | GO:0019829 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 4.19e-03 | 133 | 98 | 4 | GO:0008528 | |
| GeneOntologyMolecularFunction | basic amino acid transmembrane transporter activity | 4.28e-03 | 20 | 98 | 2 | GO:0015174 | |
| GeneOntologyMolecularFunction | phosphatidylcholine transporter activity | 4.28e-03 | 20 | 98 | 2 | GO:0008525 | |
| GeneOntologyMolecularFunction | sphingolipid transporter activity | 4.28e-03 | 20 | 98 | 2 | GO:0046624 | |
| GeneOntologyMolecularFunction | antiporter activity | 4.78e-03 | 138 | 98 | 4 | GO:0015297 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 5.03e-03 | 140 | 98 | 4 | GO:0001653 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 5.56e-03 | 73 | 98 | 3 | GO:0170055 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 5.78e-03 | 74 | 98 | 3 | GO:0005548 | |
| GeneOntologyMolecularFunction | gated channel activity | 6.08e-03 | 334 | 98 | 6 | GO:0022836 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 6.55e-03 | 151 | 98 | 4 | GO:0015085 | |
| GeneOntologyMolecularFunction | solute:proton symporter activity | 6.65e-03 | 25 | 98 | 2 | GO:0015295 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 7.18e-03 | 26 | 98 | 2 | GO:0031420 | |
| GeneOntologyMolecularFunction | bicarbonate transmembrane transporter activity | 1.07e-02 | 32 | 98 | 2 | GO:0015106 | |
| GeneOntologyMolecularFunction | solute:inorganic anion antiporter activity | 1.07e-02 | 32 | 98 | 2 | GO:0005452 | |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 1.21e-02 | 34 | 98 | 2 | GO:0042910 | |
| GeneOntologyBiologicalProcess | sensory perception of bitter taste | ITPR3 TAS2R14 TAS2R33 TAS2R36 TAS2R45 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 | 4.54e-18 | 48 | 99 | 12 | GO:0050913 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of bitter taste | TAS2R14 TAS2R33 TAS2R36 TAS2R45 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 | 1.18e-16 | 44 | 99 | 11 | GO:0001580 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of taste | TAS2R14 TAS2R33 TAS2R36 TAS2R45 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 | 5.63e-16 | 50 | 99 | 11 | GO:0050912 |
| GeneOntologyBiologicalProcess | sensory perception of taste | ITPR3 TAS2R14 TAS2R33 TAS2R36 TAS2R45 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 | 6.35e-16 | 70 | 99 | 12 | GO:0050909 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | VN1R2 GALR1 OR1S1 FPR1 OR4C45 ADGRV1 ADCY8 ITPR3 OR51E2 GHRHR OR2B11 CELSR1 TAS2R14 OR2A12 GPR142 TAS2R33 TAS2R36 MTNR1A OPN5 TAS2R45 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 ATP2B4 GPR176 CX3CR1 | 1.28e-12 | 1395 | 99 | 30 | GO:0007186 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | CACNA1F OR1S1 OR4C45 ADGRV1 OR51E2 OR2B11 TAS2R14 OR2A12 TAS2R33 TAS2R36 SCN1A SCN10A TAS2R45 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 | 3.99e-12 | 582 | 99 | 20 | GO:0050906 |
| GeneOntologyBiologicalProcess | detection of stimulus | CACNA1F OR1S1 OR4C45 ADGRV1 OR51E2 OR2B11 TAS2R14 OR2A12 TAS2R33 TAS2R36 SCN1A SCN10A OPN5 TAS2R45 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 | 2.48e-11 | 722 | 99 | 21 | GO:0051606 |
| GeneOntologyBiologicalProcess | sensory perception | VN1R2 CACNA1F OR1S1 OR4C45 ADGRV1 ITPR3 OR51E2 OR2B11 TAS2R14 OR2A12 P2RX7 TAS2R33 TAS2R36 SCN1A SCN8A SCN10A OPN5 TAS2R45 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 | 2.69e-11 | 1072 | 99 | 25 | GO:0007600 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | VN1R2 OR1S1 OR4C45 ITPR3 OR51E2 OR2B11 TAS2R14 OR2A12 TAS2R33 TAS2R36 TAS2R45 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 | 1.10e-10 | 547 | 99 | 18 | GO:0007606 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLC12A6 CACNA1F SLC22A11 FLVCR2 OTOP3 SLC13A2 SLC1A6 SLC22A7 SLC39A8 ABCB1 ITPR3 SLC22A9 P2RX7 NALCN SLC15A1 SLC15A2 SLC26A7 SCN1A SCN4A SCN7A SCN8A SCN10A SLC47A1 ATP13A3 SLC41A1 ATP2B1 ATP2B4 | 1.76e-10 | 1374 | 99 | 27 | GO:0006811 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR1S1 OR4C45 OR51E2 OR2B11 TAS2R14 OR2A12 TAS2R33 TAS2R36 TAS2R45 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 | 1.29e-09 | 485 | 99 | 16 | GO:0050907 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR1S1 OR4C45 OR51E2 OR2B11 TAS2R14 OR2A12 TAS2R33 TAS2R36 TAS2R45 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 | 3.89e-09 | 524 | 99 | 16 | GO:0009593 |
| GeneOntologyBiologicalProcess | carboxylic acid transport | SLC36A4 SLC22A11 SLC19A2 SLC13A2 SLC1A6 SLC22A7 ABCB1 ABCB4 SLC22A9 P2RX7 SLC26A7 SLC47A1 SLC25A29 SLC7A10 | 9.88e-09 | 410 | 99 | 14 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | SLC36A4 SLC22A11 SLC19A2 SLC13A2 SLC1A6 SLC22A7 ABCB1 ABCB4 SLC22A9 P2RX7 SLC26A7 SLC47A1 SLC25A29 SLC7A10 | 1.05e-08 | 412 | 99 | 14 | GO:0015849 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SLC12A6 CACNA1F OTOP3 SLC13A2 SLC39A8 ABCB1 ITPR3 P2RX7 NALCN SLC15A1 SLC15A2 SLC26A7 SCN1A SCN4A SCN7A SCN8A SCN10A SLC47A1 ATP13A3 SLC41A1 ATP2B1 ATP2B4 | 1.14e-08 | 1115 | 99 | 22 | GO:0034220 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SLC12A6 CACNA1F OTOP3 SLC13A2 SLC39A8 ITPR3 P2RX7 NALCN SLC15A1 SLC15A2 SCN1A SCN4A SCN7A SCN8A SCN10A SLC47A1 ATP13A3 SLC41A1 ATP2B1 ATP2B4 | 1.78e-08 | 942 | 99 | 20 | GO:0098655 |
| GeneOntologyBiologicalProcess | organic anion transport | SLC36A4 SLC22A11 SLC19A2 SLC13A2 SLC1A6 SLC22A7 SLC39A8 ABCB1 ABCB4 SLC22A9 P2RX7 SLC26A7 SLC47A1 SLC25A29 SLC7A10 | 2.34e-08 | 515 | 99 | 15 | GO:0015711 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SLC12A6 CACNA1F OTOP3 SLC13A2 SLC39A8 ITPR3 P2RX7 NALCN SLC15A1 SLC15A2 SLC26A7 SCN1A SCN4A SCN7A SCN8A SCN10A SLC47A1 SLC41A1 ATP2B1 ATP2B4 | 6.30e-08 | 1017 | 99 | 20 | GO:0098660 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SLC12A6 CACNA1F OTOP3 SLC13A2 SLC39A8 ITPR3 P2RX7 NALCN SLC15A1 SLC15A2 SCN1A SCN4A SCN7A SCN8A SCN10A SLC47A1 SLC41A1 ATP2B1 ATP2B4 | 6.85e-08 | 922 | 99 | 19 | GO:0098662 |
| GeneOntologyBiologicalProcess | carboxylic acid transmembrane transport | SLC36A4 SLC13A2 SLC1A6 ABCB1 SLC22A9 SLC26A7 SLC47A1 SLC25A29 SLC7A10 | 9.08e-08 | 163 | 99 | 9 | GO:1905039 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SLC12A6 CACNA1F FLVCR2 OTOP3 SLC13A2 SLC39A8 ITPR3 P2RX7 NALCN SLC15A1 SLC15A2 SCN1A SCN4A SCN7A SCN8A SCN10A SLC47A1 ATP13A3 SLC41A1 ATP2B1 ATP2B4 | 1.08e-07 | 1157 | 99 | 21 | GO:0006812 |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | SLC36A4 SLC13A2 SLC1A6 ABCB1 SLC22A9 SLC26A7 SLC47A1 SLC25A29 SLC7A10 | 1.12e-07 | 167 | 99 | 9 | GO:1903825 |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 7.17e-07 | 208 | 99 | 9 | GO:0035725 | |
| GeneOntologyBiologicalProcess | sodium ion transport | SLC13A2 P2RX7 NALCN SCN1A SCN4A SCN7A SCN8A SCN10A SLC41A1 ATP2B4 | 8.27e-07 | 275 | 99 | 10 | GO:0006814 |
| GeneOntologyBiologicalProcess | import across plasma membrane | SLC12A6 CACNA1F SLC36A4 SLC1A6 SLC39A8 SLC15A1 SLC15A2 SLC47A1 ATP2B4 | 1.65e-06 | 230 | 99 | 9 | GO:0098739 |
| GeneOntologyBiologicalProcess | organic cation transport | 6.37e-06 | 145 | 99 | 7 | GO:0015695 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 1.20e-05 | 62 | 99 | 5 | GO:0086002 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 1.30e-05 | 63 | 99 | 5 | GO:0019228 | |
| GeneOntologyBiologicalProcess | xenobiotic transport | 1.40e-05 | 64 | 99 | 5 | GO:0042908 | |
| GeneOntologyBiologicalProcess | metal ion transport | SLC12A6 CACNA1F FLVCR2 SLC13A2 SLC39A8 ITPR3 P2RX7 NALCN SCN1A SCN4A SCN7A SCN8A SCN10A SLC41A1 ATP2B1 ATP2B4 | 2.12e-05 | 1000 | 99 | 16 | GO:0030001 |
| GeneOntologyBiologicalProcess | tripeptide import across plasma membrane | 2.28e-05 | 2 | 99 | 2 | GO:0140207 | |
| GeneOntologyBiologicalProcess | dicarboxylic acid transport | 2.47e-05 | 120 | 99 | 6 | GO:0006835 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 2.61e-05 | 36 | 99 | 4 | GO:0086010 | |
| GeneOntologyBiologicalProcess | amino acid transport | 4.33e-05 | 195 | 99 | 7 | GO:0006865 | |
| GeneOntologyBiologicalProcess | azole transmembrane transport | 4.68e-05 | 15 | 99 | 3 | GO:0045117 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 6.23e-05 | 87 | 99 | 5 | GO:0086001 | |
| GeneOntologyBiologicalProcess | L-alpha-amino acid transmembrane transport | 6.23e-05 | 87 | 99 | 5 | GO:1902475 | |
| GeneOntologyBiologicalProcess | ceramide translocation | 6.82e-05 | 3 | 99 | 2 | GO:0099040 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 7.13e-05 | 286 | 99 | 8 | GO:0007188 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 8.56e-05 | 93 | 99 | 5 | GO:0086003 | |
| GeneOntologyBiologicalProcess | xenobiotic transmembrane transport | 9.83e-05 | 19 | 99 | 3 | GO:0006855 | |
| GeneOntologyBiologicalProcess | positive regulation of cytosolic calcium ion concentration | 1.04e-04 | 224 | 99 | 7 | GO:0007204 | |
| GeneOntologyBiologicalProcess | calcium ion export | 1.36e-04 | 4 | 99 | 2 | GO:1901660 | |
| GeneOntologyBiologicalProcess | putrescine transport | 1.36e-04 | 4 | 99 | 2 | GO:0015847 | |
| GeneOntologyBiologicalProcess | phospholipid translocation | 1.41e-04 | 55 | 99 | 4 | GO:0045332 | |
| GeneOntologyBiologicalProcess | L-amino acid transport | 1.73e-04 | 108 | 99 | 5 | GO:0015807 | |
| GeneOntologyBiologicalProcess | amide transport | 1.90e-04 | 420 | 99 | 9 | GO:0042886 | |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | SLC12A6 CACNA1F ADCY8 SLC39A8 ITPR3 P2RX7 SCN7A ATP13A3 SLC41A1 ATP2B1 ATP2B4 | 1.96e-04 | 622 | 99 | 11 | GO:0098771 |
| GeneOntologyBiologicalProcess | lipid translocation | 1.98e-04 | 60 | 99 | 4 | GO:0034204 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 2.06e-04 | 112 | 99 | 5 | GO:0019226 | |
| GeneOntologyBiologicalProcess | oligopeptide import across plasma membrane | 2.26e-04 | 5 | 99 | 2 | GO:0140205 | |
| GeneOntologyBiologicalProcess | dipeptide import across plasma membrane | 2.26e-04 | 5 | 99 | 2 | GO:0140206 | |
| GeneOntologyBiologicalProcess | sphingolipid translocation | 2.26e-04 | 5 | 99 | 2 | GO:0099039 | |
| GeneOntologyBiologicalProcess | regulation of membrane lipid distribution | 2.70e-04 | 65 | 99 | 4 | GO:0097035 | |
| GeneOntologyBiologicalProcess | amino acid transmembrane transport | 2.83e-04 | 120 | 99 | 5 | GO:0003333 | |
| GeneOntologyBiologicalProcess | xenobiotic detoxification by transmembrane export across the plasma membrane | 2.89e-04 | 27 | 99 | 3 | GO:1990961 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 2.95e-04 | 121 | 99 | 5 | GO:0051899 | |
| GeneOntologyBiologicalProcess | positive regulation of phospholipid translocation | 3.38e-04 | 6 | 99 | 2 | GO:0061092 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | SLC1A6 SLC39A8 PANK2 P2RX7 NALCN SCN1A SCN4A SCN7A SCN8A SCN10A | 3.54e-04 | 559 | 99 | 10 | GO:0042391 |
| GeneOntologyBiologicalProcess | xenobiotic export from cell | 3.58e-04 | 29 | 99 | 3 | GO:0046618 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 3.68e-04 | 127 | 99 | 5 | GO:0070252 | |
| GeneOntologyBiologicalProcess | action potential | 4.20e-04 | 201 | 99 | 6 | GO:0001508 | |
| GeneOntologyBiologicalProcess | regulation of phospholipid translocation | 4.71e-04 | 7 | 99 | 2 | GO:0061091 | |
| GeneOntologyBiologicalProcess | alpha-ketoglutarate transport | 4.71e-04 | 7 | 99 | 2 | GO:0015742 | |
| GeneOntologyBiologicalProcess | thiamine transmembrane transport | 4.71e-04 | 7 | 99 | 2 | GO:0071934 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | SLC12A6 CACNA1F ADCY8 SLC39A8 ITPR3 P2RX7 SCN7A ATP13A3 SLC41A1 ATP2B1 ATP2B4 | 5.65e-04 | 705 | 99 | 11 | GO:0055080 |
| GeneOntologyBiologicalProcess | monocarboxylic acid transport | 5.70e-04 | 213 | 99 | 6 | GO:0015718 | |
| GeneOntologyBiologicalProcess | prostaglandin transport | 5.76e-04 | 34 | 99 | 3 | GO:0015732 | |
| GeneOntologyBiologicalProcess | heart contraction | 5.87e-04 | 298 | 99 | 7 | GO:0060047 | |
| GeneOntologyBiologicalProcess | dipeptide transport | 6.27e-04 | 8 | 99 | 2 | GO:0042938 | |
| GeneOntologyBiologicalProcess | thiamine transport | 6.27e-04 | 8 | 99 | 2 | GO:0015888 | |
| GeneOntologyBiologicalProcess | dipeptide transmembrane transport | 6.27e-04 | 8 | 99 | 2 | GO:0035442 | |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | SLC12A6 CACNA1F ADCY8 SLC39A8 ITPR3 P2RX7 SCN7A ATP13A3 SLC41A1 ATP2B1 ATP2B4 | 6.50e-04 | 717 | 99 | 11 | GO:0050801 |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | CACNA1F ADCY8 SLC39A8 ITPR3 P2RX7 SCN7A ATP13A3 SLC41A1 ATP2B1 ATP2B4 | 7.07e-04 | 611 | 99 | 10 | GO:0030003 |
| GeneOntologyBiologicalProcess | heart process | 7.26e-04 | 309 | 99 | 7 | GO:0003015 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | CACNA1F ADCY8 SLC39A8 ITPR3 P2RX7 SCN7A ATP13A3 SLC41A1 ATP2B1 ATP2B4 | 8.10e-04 | 622 | 99 | 10 | GO:0006873 |
| GeneOntologyBiologicalProcess | actin filament-based movement | 8.59e-04 | 153 | 99 | 5 | GO:0030048 | |
| GeneOntologyBiologicalProcess | export across plasma membrane | 9.69e-04 | 91 | 99 | 4 | GO:0140115 | |
| GeneOntologyBiologicalProcess | tripeptide transmembrane transport | 1.00e-03 | 10 | 99 | 2 | GO:0035443 | |
| GeneOntologyBiologicalProcess | export from cell | TRAPPC11 MICAL1 GALR1 PFKM ADCY8 ABCB1 EFR3A OR51E2 GHRHR P2RX7 SLC15A2 MTNR1A SLC47A1 ATP2B1 | 1.19e-03 | 1153 | 99 | 14 | GO:0140352 |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 1.27e-03 | 167 | 99 | 5 | GO:0060048 | |
| GeneOntologyBiologicalProcess | detoxification | 1.37e-03 | 170 | 99 | 5 | GO:0098754 | |
| GeneOntologyBiologicalProcess | positive regulation of lipid transport | 1.48e-03 | 102 | 99 | 4 | GO:0032370 | |
| GeneOntologyBiologicalProcess | detection of external stimulus | 1.48e-03 | 173 | 99 | 5 | GO:0009581 | |
| GeneOntologyBiologicalProcess | detection of abiotic stimulus | 1.56e-03 | 175 | 99 | 5 | GO:0009582 | |
| GeneOntologyBiologicalProcess | positive regulation of bone mineralization | 1.68e-03 | 49 | 99 | 3 | GO:0030501 | |
| GeneOntologyBiologicalProcess | phospholipid transport | 1.71e-03 | 106 | 99 | 4 | GO:0015914 | |
| GeneOntologyBiologicalProcess | tripeptide transport | 1.72e-03 | 13 | 99 | 2 | GO:0042939 | |
| GeneOntologyBiologicalProcess | aromatic amino acid transport | 1.72e-03 | 13 | 99 | 2 | GO:0015801 | |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | 1.73e-03 | 359 | 99 | 7 | GO:0006874 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 2.29e-03 | 191 | 99 | 5 | GO:0007189 | |
| GeneOntologyBiologicalProcess | L-arginine transmembrane transport | 2.30e-03 | 15 | 99 | 2 | GO:1903826 | |
| GeneOntologyBiologicalProcess | positive regulation of phospholipid transport | 2.30e-03 | 15 | 99 | 2 | GO:2001140 | |
| GeneOntologyCellularComponent | apical plasma membrane | SLC12A6 SLC2A7 SLC22A11 PFKM SLC13A2 SLC22A7 ADCY8 SLC39A8 ABCB1 ABCB4 ITPR3 SLC15A1 SLC15A2 SLC26A7 PROM2 TMEM30A SLC47A1 ATP2B1 | 1.58e-11 | 487 | 100 | 18 | GO:0016324 |
| GeneOntologyCellularComponent | apical part of cell | SLC12A6 SLC2A7 SLC22A11 PFKM SLC13A2 SLC22A7 ADCY8 SLC39A8 ABCB1 ABCB4 ITPR3 SLC15A1 SLC15A2 SLC26A7 PROM2 TMEM30A SLC47A1 ATP2B1 | 3.77e-10 | 592 | 100 | 18 | GO:0045177 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 1.34e-08 | 17 | 100 | 5 | GO:0001518 | |
| GeneOntologyCellularComponent | basal plasma membrane | SLC12A6 SLC22A11 SLC22A7 ADCY8 SLC39A8 SLC22A9 SLC26A7 PROM2 SLC47A1 SLC41A1 ATP2B1 ATP2B4 | 1.28e-07 | 354 | 100 | 12 | GO:0009925 |
| GeneOntologyCellularComponent | sodium channel complex | 2.46e-07 | 29 | 100 | 5 | GO:0034706 | |
| GeneOntologyCellularComponent | basal part of cell | SLC12A6 SLC22A11 SLC22A7 ADCY8 SLC39A8 SLC22A9 SLC26A7 PROM2 SLC47A1 SLC41A1 ATP2B1 ATP2B4 | 2.58e-07 | 378 | 100 | 12 | GO:0045178 |
| GeneOntologyCellularComponent | basolateral plasma membrane | SLC12A6 SLC22A7 ADCY8 SLC39A8 SLC22A9 SLC26A7 PROM2 SLC47A1 SLC41A1 ATP2B1 ATP2B4 | 3.84e-07 | 320 | 100 | 11 | GO:0016323 |
| GeneOntologyCellularComponent | motile cilium | CD52 PFKM TAS2R45 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 ATP2B4 | 1.07e-06 | 355 | 100 | 11 | GO:0031514 |
| GeneOntologyCellularComponent | cilium | CACNA1F CD52 ADGRV1 PFKM PROM2 KIF3C TAS2R45 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 ATP2B4 | 2.33e-05 | 898 | 100 | 15 | GO:0005929 |
| GeneOntologyCellularComponent | presynaptic membrane | 3.73e-04 | 277 | 100 | 7 | GO:0042734 | |
| GeneOntologyCellularComponent | intercellular canaliculus | 7.98e-04 | 9 | 100 | 2 | GO:0046581 | |
| GeneOntologyCellularComponent | cation channel complex | 9.36e-04 | 235 | 100 | 6 | GO:0034703 | |
| GeneOntologyCellularComponent | neuronal cell body membrane | 1.14e-03 | 43 | 100 | 3 | GO:0032809 | |
| GeneOntologyCellularComponent | cell body membrane | 1.48e-03 | 47 | 100 | 3 | GO:0044298 | |
| GeneOntologyCellularComponent | neuronal cell body | CACNA1F ADCY8 ITPR3 P2RX7 SCN1A SCN8A MTNR1A KIF3C ATP2B1 SLC7A10 CX3CR1 | 2.15e-03 | 835 | 100 | 11 | GO:0043025 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 2.27e-03 | 378 | 100 | 7 | GO:0034702 | |
| HumanPheno | Exercise-induced muscle fatigue | 3.17e-05 | 12 | 28 | 3 | HP:0009020 | |
| HumanPheno | Focal automatism seizure | 3.17e-05 | 12 | 28 | 3 | HP:0032898 | |
| Domain | TAS2R | TAS2R14 TAS2R45 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 | 4.96e-15 | 26 | 96 | 9 | PF05296 |
| Domain | T2R | TAS2R14 TAS2R45 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 | 4.96e-15 | 26 | 96 | 9 | IPR007960 |
| Domain | Na_channel_asu | 7.97e-10 | 10 | 96 | 5 | IPR001696 | |
| Domain | Na_trans_assoc | 7.97e-10 | 10 | 96 | 5 | IPR010526 | |
| Domain | Na_trans_assoc | 7.97e-10 | 10 | 96 | 5 | PF06512 | |
| Domain | Channel_four-helix_dom | 1.63e-08 | 57 | 96 | 7 | IPR027359 | |
| Domain | - | 1.63e-08 | 57 | 96 | 7 | 1.20.120.350 | |
| Domain | MFS_dom | SLC2A7 SLC22A11 SLC19A2 MFSD6L FLVCR2 SLC22A7 SLC22A9 SLC15A1 SLC15A2 | 2.94e-08 | 134 | 96 | 9 | IPR020846 |
| Domain | Ion_trans_dom | 1.28e-07 | 114 | 96 | 8 | IPR005821 | |
| Domain | Ion_trans | 1.28e-07 | 114 | 96 | 8 | PF00520 | |
| Domain | MFS | 1.98e-05 | 108 | 96 | 6 | PS50850 | |
| Domain | ATP2B1/4 | 2.61e-05 | 2 | 96 | 2 | IPR030319 | |
| Domain | Oligopep_transport | 2.61e-05 | 2 | 96 | 2 | IPR004768 | |
| Domain | PTR2_symporter_CS | 7.82e-05 | 3 | 96 | 2 | IPR018456 | |
| Domain | PTR2_1 | 7.82e-05 | 3 | 96 | 2 | PS01022 | |
| Domain | ATPase_P-typ_cation-transptr_C | 8.49e-05 | 17 | 96 | 3 | IPR006068 | |
| Domain | Cation_ATPase_C | 8.49e-05 | 17 | 96 | 3 | PF00689 | |
| Domain | IQ_motif_EF-hand-BS | 1.01e-04 | 90 | 96 | 5 | IPR000048 | |
| Domain | Cation_ATPase_N | 1.02e-04 | 18 | 96 | 3 | PF00690 | |
| Domain | ATPase_P-typ_cation-transptr_N | 1.20e-04 | 19 | 96 | 3 | IPR004014 | |
| Domain | ATP_Ca_trans_C | 1.56e-04 | 4 | 96 | 2 | IPR022141 | |
| Domain | ATP_Ca_trans_C | 1.56e-04 | 4 | 96 | 2 | PF12424 | |
| Domain | P-type_ATPase_IIB | 1.56e-04 | 4 | 96 | 2 | IPR006408 | |
| Domain | PTR2_2 | 1.56e-04 | 4 | 96 | 2 | PS01023 | |
| Domain | GPCR_Rhodpsn_7TM | VN1R2 GALR1 OR1S1 FPR1 OR51E2 OR2B11 OR2A12 GPR142 MTNR1A OPN5 GPR176 CX3CR1 | 1.63e-04 | 670 | 96 | 12 | IPR017452 |
| Domain | G_PROTEIN_RECEP_F1_1 | VN1R2 GALR1 OR1S1 FPR1 OR51E2 OR2B11 OR2A12 GPR142 MTNR1A OPN5 GPR176 CX3CR1 | 2.01e-04 | 685 | 96 | 12 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | VN1R2 GALR1 OR1S1 FPR1 OR51E2 OR2B11 OR2A12 GPR142 MTNR1A OPN5 GPR176 CX3CR1 | 2.17e-04 | 691 | 96 | 12 | PS50262 |
| Domain | GPCR_Rhodpsn | VN1R2 GALR1 OR1S1 FPR1 OR51E2 OR2B11 OR2A12 GPR142 MTNR1A OPN5 GPR176 CX3CR1 | 2.20e-04 | 692 | 96 | 12 | IPR000276 |
| Domain | POT_fam | 2.59e-04 | 5 | 96 | 2 | IPR000109 | |
| Domain | PTR2 | 2.59e-04 | 5 | 96 | 2 | PF00854 | |
| Domain | Na_trans_cytopl | 3.87e-04 | 6 | 96 | 2 | PF11933 | |
| Domain | Na_trans_cytopl | 3.87e-04 | 6 | 96 | 2 | IPR024583 | |
| Domain | IQ | 4.89e-04 | 71 | 96 | 4 | PF00612 | |
| Domain | MFS_1 | 6.66e-04 | 77 | 96 | 4 | PF07690 | |
| Domain | MFS | 6.66e-04 | 77 | 96 | 4 | IPR011701 | |
| Domain | 7tm_1 | GALR1 OR1S1 FPR1 OR51E2 OR2B11 OR2A12 GPR142 MTNR1A OPN5 GPR176 CX3CR1 | 7.04e-04 | 677 | 96 | 11 | PF00001 |
| Domain | ATPase_P-typ_cyto_domN | 7.64e-04 | 35 | 96 | 3 | IPR023299 | |
| Domain | IQ | 8.06e-04 | 81 | 96 | 4 | SM00015 | |
| Domain | P_typ_ATPase | 8.31e-04 | 36 | 96 | 3 | IPR001757 | |
| Domain | ATPase_P-typ_P_site | 8.31e-04 | 36 | 96 | 3 | IPR018303 | |
| Domain | ATPASE_E1_E2 | 8.31e-04 | 36 | 96 | 3 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 9.01e-04 | 37 | 96 | 3 | IPR008250 | |
| Domain | E1-E2_ATPase | 9.01e-04 | 37 | 96 | 3 | PF00122 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 1.13e-03 | 40 | 96 | 3 | PS00649 | |
| Domain | GPCR_2_extracellular_dom | 1.13e-03 | 40 | 96 | 3 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 1.13e-03 | 40 | 96 | 3 | PS50227 | |
| Domain | IQ | 1.35e-03 | 93 | 96 | 4 | PS50096 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 2.17e-03 | 50 | 96 | 3 | PS00650 | |
| Domain | 7tm_2 | 2.17e-03 | 50 | 96 | 3 | PF00002 | |
| Domain | - | 2.99e-03 | 16 | 96 | 2 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_TM_dom | 2.99e-03 | 16 | 96 | 2 | IPR023298 | |
| Domain | GPCR_2_secretin-like | 3.64e-03 | 60 | 96 | 3 | IPR000832 | |
| Domain | GPCR_2-like | 3.64e-03 | 60 | 96 | 3 | IPR017981 | |
| Domain | Cation_ATPase_N | 3.79e-03 | 18 | 96 | 2 | SM00831 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 3.82e-03 | 61 | 96 | 3 | PS50261 | |
| Domain | ConA-like_dom | 5.46e-03 | 219 | 96 | 5 | IPR013320 | |
| Domain | AA-permease/SLC12A_dom | 5.65e-03 | 22 | 96 | 2 | IPR004841 | |
| Domain | AA_permease | 5.65e-03 | 22 | 96 | 2 | PF00324 | |
| Domain | ABC_membrane | 6.70e-03 | 24 | 96 | 2 | PF00664 | |
| Domain | HormR | 7.26e-03 | 25 | 96 | 2 | SM00008 | |
| Domain | HAD-like_dom | 7.85e-03 | 79 | 96 | 3 | IPR023214 | |
| Domain | ABC_TM1F | 9.06e-03 | 28 | 96 | 2 | PS50929 | |
| Domain | ABC1_TM_dom | 9.06e-03 | 28 | 96 | 2 | IPR011527 | |
| Domain | HRM | 9.06e-03 | 28 | 96 | 2 | PF02793 | |
| Pathway | REACTOME_SENSORY_PERCEPTION_OF_TASTE | ITPR3 TAS2R14 TAS2R45 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 | 4.55e-16 | 31 | 76 | 10 | MM15691 |
| Pathway | KEGG_TASTE_TRANSDUCTION | ADCY8 ITPR3 TAS2R14 TAS2R45 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R46 TAS2R50 | 1.48e-13 | 52 | 76 | 10 | M5785 |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | TAS2R14 TAS2R45 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 | 2.60e-13 | 37 | 76 | 9 | MM15067 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC12A6 SLC36A4 SLC2A7 SLC22A11 SLC13A2 SLC1A6 SLC22A7 SLC39A8 SLC15A1 SLC15A2 SLC26A7 SLC47A1 SLC25A29 SLC41A1 SLC7A10 | 3.63e-12 | 249 | 76 | 15 | M5988 |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | TAS2R14 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 | 2.63e-11 | 39 | 76 | 8 | M793 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC12A6 SLC36A4 SLC2A7 SLC13A2 SLC1A6 SLC22A7 SLC39A8 SLC15A1 SLC15A2 SLC26A7 SLC47A1 SLC25A29 SLC41A1 SLC7A10 | 2.83e-11 | 238 | 76 | 14 | MM15076 |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | GALR1 FPR1 ADCY8 TAS2R14 MTNR1A OPN5 TAS2R45 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 CX3CR1 | 3.06e-11 | 289 | 76 | 15 | MM15057 |
| Pathway | WP_GPCRS_ODORANT | GPR137 TAS2R14 GPR142 TAS2R45 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 GPR176 | 4.00e-11 | 157 | 76 | 12 | MM15872 |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | GALR1 FPR1 ADCY8 ITPR3 TAS2R14 MTNR1A OPN5 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 CX3CR1 | 9.86e-11 | 314 | 76 | 15 | M600 |
| Pathway | REACTOME_SENSORY_PERCEPTION_OF_TASTE | ITPR3 TAS2R14 TAS2R31 TAS2R43 TAS2R20 TAS2R30 TAS2R46 TAS2R50 | 1.30e-10 | 47 | 76 | 8 | M42524 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC12A6 SLC36A4 SLC2A7 SLC22A11 SLC13A2 SLC1A6 SLC22A7 ADCY8 SLC39A8 ABCB1 ABCB4 NALCN SLC15A1 SLC15A2 SLC26A7 SLC47A1 SLC25A29 SLC41A1 ATP2B1 SLC7A10 ATP2B4 | 1.71e-10 | 736 | 76 | 21 | M27287 |
| Pathway | REACTOME_SENSORY_PERCEPTION | ITPR3 OR51E2 OR2B11 TAS2R14 TAS2R45 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 | 3.71e-10 | 190 | 76 | 12 | MM15687 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC12A6 SLC36A4 SLC2A7 SLC13A2 SLC1A6 SLC22A7 SLC39A8 ABCB1 ABCB4 NALCN SLC15A1 SLC15A2 SLC26A7 SLC47A1 SLC25A29 SLC41A1 ATP2B1 SLC7A10 ATP2B4 | 2.21e-09 | 681 | 76 | 19 | MM14985 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | GALR1 FPR1 ADCY8 ITPR3 GHRHR TAS2R14 MTNR1A OPN5 TAS2R45 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 GPR176 CX3CR1 | 6.50e-09 | 646 | 76 | 18 | MM14962 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | GALR1 FPR1 GHRHR TAS2R14 MTNR1A OPN5 TAS2R45 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 CX3CR1 | 7.47e-09 | 430 | 76 | 15 | MM15160 |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | SLC12A6 SLC36A4 SLC1A6 SLC15A1 SLC15A2 SLC26A7 SLC25A29 SLC7A10 | 1.12e-07 | 108 | 76 | 8 | M823 |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | SLC12A6 SLC36A4 SLC1A6 SLC15A1 SLC15A2 SLC26A7 SLC25A29 SLC7A10 | 1.20e-07 | 109 | 76 | 8 | MM15074 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | GALR1 FPR1 ADCY8 ITPR3 GHRHR TAS2R14 MTNR1A OPN5 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 GPR176 CX3CR1 | 1.42e-07 | 702 | 76 | 17 | M746 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | GALR1 FPR1 GHRHR TAS2R14 MTNR1A OPN5 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 CX3CR1 | 1.49e-07 | 463 | 76 | 14 | M507 |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 4.69e-07 | 130 | 76 | 8 | M27454 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 6.07e-07 | 31 | 76 | 5 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 7.16e-07 | 32 | 76 | 5 | M27455 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 5.85e-06 | 84 | 76 | 6 | M27334 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR1S1 OR4C45 ITPR3 OR51E2 OR2B11 TAS2R14 OR2A12 TAS2R31 TAS2R43 TAS2R20 TAS2R30 TAS2R46 TAS2R50 ATP2B1 | 6.45e-06 | 636 | 76 | 14 | M41834 |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 1.25e-05 | 27 | 76 | 4 | MM15053 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 1.31e-05 | 203 | 76 | 8 | M5485 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 1.45e-05 | 28 | 76 | 4 | M924 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 5.46e-05 | 76 | 76 | 5 | MM15072 | |
| Pathway | WP_GPCRS_NONODORANT | 9.00e-05 | 266 | 76 | 8 | MM15843 | |
| Pathway | WP_PROXIMAL_TUBULE_TRANSPORT | 2.48e-04 | 57 | 76 | 4 | M39812 | |
| Pathway | REACTOME_ORGANIC_ANION_TRANSPORT | 2.84e-04 | 5 | 76 | 2 | M27469 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 3.92e-04 | 178 | 76 | 6 | M2890 | |
| Pathway | BIOCARTA_MRP_PATHWAY | 4.24e-04 | 6 | 76 | 2 | M22078 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 4.87e-04 | 121 | 76 | 5 | M872 | |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 6.67e-04 | 32 | 76 | 3 | MM14957 | |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 7.31e-04 | 33 | 76 | 3 | M188 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 7.46e-04 | 76 | 76 | 4 | MM15051 | |
| Pathway | WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION | 9.46e-04 | 36 | 76 | 3 | M39831 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 1.19e-03 | 86 | 76 | 4 | M916 | |
| Pathway | WP_GPCRS_OTHER | 1.58e-03 | 93 | 76 | 4 | M39629 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 1.83e-03 | 12 | 76 | 2 | M27326 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 2.15e-03 | 13 | 76 | 2 | MM14553 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 2.50e-03 | 14 | 76 | 2 | MM15052 | |
| Pathway | REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT | 2.88e-03 | 15 | 76 | 2 | M888 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 3.07e-03 | 54 | 76 | 3 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 3.07e-03 | 54 | 76 | 3 | MM15202 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 3.28e-03 | 16 | 76 | 2 | M26945 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY | 3.70e-03 | 17 | 76 | 2 | M47544 | |
| Pubmed | TAS2R14 TAS2R45 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 | 6.57e-21 | 13 | 100 | 9 | 15938754 | |
| Pubmed | The human TAS2R16 receptor mediates bitter taste in response to beta-glucopyranosides. | TAS2R45 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 | 1.72e-18 | 12 | 100 | 8 | 12379855 |
| Pubmed | TAS2R14 TAS2R45 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 | 2.65e-18 | 21 | 100 | 9 | 10761934 | |
| Pubmed | Evolutionary relationships of the Tas2r receptor gene families in mouse and human. | TAS2R14 TAS2R45 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 | 4.48e-18 | 22 | 100 | 9 | 12734386 |
| Pubmed | TAS2R14 TAS2R45 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 | 1.83e-17 | 25 | 100 | 9 | 12139982 | |
| Pubmed | Molecular mechanisms of bitter and sweet taste transduction. | TAS2R14 TAS2R45 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 | 2.79e-17 | 26 | 100 | 9 | 11696554 |
| Pubmed | TAS2R14 TAS2R45 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 | 4.17e-17 | 27 | 100 | 9 | 12581520 | |
| Pubmed | Mapping of QTLs for oral alcohol self-administration in B6.C and B6.I quasi-congenic RQI strains. | TAS2R14 TAS2R45 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 | 1.26e-16 | 30 | 100 | 9 | 17273929 |
| Pubmed | Adaptive diversification of bitter taste receptor genes in Mammalian evolution. | TAS2R14 TAS2R45 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 | 1.26e-16 | 30 | 100 | 9 | 12679530 |
| Pubmed | The molecular receptive ranges of human TAS2R bitter taste receptors. | TAS2R14 TAS2R45 TAS2R31 TAS2R43 TAS2R19 TAS2R30 TAS2R46 TAS2R50 | 1.66e-15 | 23 | 100 | 8 | 20022913 |
| Pubmed | Lineage-specific loss of function of bitter taste receptor genes in humans and nonhuman primates. | TAS2R14 TAS2R45 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 | 1.04e-14 | 28 | 100 | 8 | 15744053 |
| Pubmed | TAS2R14 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 | 5.99e-14 | 34 | 100 | 8 | 15496549 | |
| Pubmed | Identification and characterization of human taste receptor genes belonging to the TAS2R family. | 2.24e-10 | 13 | 100 | 5 | 12584440 | |
| Pubmed | 8.02e-09 | 9 | 100 | 4 | 16382098 | ||
| Pubmed | Opposing effects of the purinergic P2X7 receptor on seizures in neurons and microglia in male mice. | 2.31e-08 | 3 | 100 | 3 | 38777288 | |
| Pubmed | Screening of the interaction between xenobiotic transporters and PDZ proteins. | 8.57e-08 | 15 | 100 | 4 | 15553237 | |
| Pubmed | Isolation of a family of organic anion transporters from human liver and kidney. | 9.21e-08 | 4 | 100 | 3 | 11327718 | |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 1.64e-07 | 139 | 100 | 7 | 16985003 | |
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 4.58e-07 | 6 | 100 | 3 | 23652591 | |
| Pubmed | 1.91e-06 | 9 | 100 | 3 | 15746173 | ||
| Pubmed | 3.77e-06 | 143 | 100 | 6 | 20424473 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 4.41e-06 | 38 | 100 | 4 | 30786075 | |
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 15123669 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 10488067 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 17702579 | ||
| Pubmed | Reduction of Kcnt1 is therapeutic in mouse models of SCN1A and SCN8A epilepsy. | 8.18e-06 | 2 | 100 | 2 | 37901435 | |
| Pubmed | Multidrug resistance gene expression and ABCB1 SNPs in plasma cell myeloma. | 8.18e-06 | 2 | 100 | 2 | 21705081 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 10552998 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 28441502 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 33461297 | ||
| Pubmed | Genetic dissection of the function of mammalian P-glycoproteins. | 8.18e-06 | 2 | 100 | 2 | 9196326 | |
| Pubmed | An Scn1a epilepsy mutation in Scn8a alters seizure susceptibility and behavior. | 8.18e-06 | 2 | 100 | 2 | 26410685 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 11944083 | ||
| Pubmed | MDR1 and MDR3 genes and drug resistance to cisplatin of ovarian cancer cells. | 8.18e-06 | 2 | 100 | 2 | 18231753 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 18657858 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 22184139 | ||
| Pubmed | Comparison of human and monkey peptide transporters: PEPT1 and PEPT2. | 8.18e-06 | 2 | 100 | 2 | 15981923 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 37775020 | ||
| Pubmed | Isolation and expression of a complementary DNA that confers multidrug resistance. | 8.18e-06 | 2 | 100 | 2 | 3022150 | |
| Pubmed | ABCB1/4 gallbladder cancer risk variants identified in India also show strong effects in Chileans. | 8.18e-06 | 2 | 100 | 2 | 32058310 | |
| Pubmed | Peptide transporters and their roles in physiological processes and drug disposition. | 8.18e-06 | 2 | 100 | 2 | 18668438 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 35086862 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 2570420 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 8898203 | ||
| Pubmed | Lack of interaction between the peptidomimetic substrates captopril and cephradine. | 8.18e-06 | 2 | 100 | 2 | 19246733 | |
| Pubmed | The influence of membrane lipid structure on plasma membrane Ca2+ -ATPase activity. | 8.18e-06 | 2 | 100 | 2 | 16412504 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 37101546 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 2473069 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 28274756 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 16956963 | ||
| Pubmed | Transport of angiotensin-converting enzyme inhibitors by H+/peptide transporters revisited. | 8.18e-06 | 2 | 100 | 2 | 18713951 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 19185004 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 3768958 | ||
| Pubmed | The purinergic receptor P2RX7 directs metabolic fitness of long-lived memory CD8+ T cells. | 8.18e-06 | 2 | 100 | 2 | 29973721 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 18367661 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 1674727 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 23786015 | ||
| Pubmed | Tissue distribution and thyroid hormone regulation of Pept1 and Pept2 mRNA in rodents. | 8.18e-06 | 2 | 100 | 2 | 16202478 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 15537898 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 12545080 | ||
| Pubmed | Role of ABCB1 and ABCB4 in renal and biliary excretion of perfluorooctanoic acid in mice. | 8.18e-06 | 2 | 100 | 2 | 38522903 | |
| Pubmed | Localization of the human multiple drug resistance gene, MDR1, to 7q21.1. | 8.18e-06 | 2 | 100 | 2 | 3477522 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 33411788 | ||
| Pubmed | The bioactive dipeptide anserine is transported by human proton-coupled peptide transporters. | 8.18e-06 | 2 | 100 | 2 | 20067523 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 18215618 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 15178683 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 16857572 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 31943325 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 26796213 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 1969609 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 24140176 | ||
| Pubmed | Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. | 8.18e-06 | 2 | 100 | 2 | 9419367 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 2248681 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 16291816 | ||
| Pubmed | Regulation of plasma membrane Ca2+-ATPase by small GTPases and phosphoinositides in human platelets. | 8.18e-06 | 2 | 100 | 2 | 10748016 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 17440929 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 26116539 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 7832992 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 11826402 | ||
| Pubmed | What have we learnt thus far from mice with disrupted P-glycoprotein genes? | 8.18e-06 | 2 | 100 | 2 | 8763339 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 29906129 | ||
| Pubmed | Persistent Nav1.1 and Nav1.6 currents drive spinal locomotor functions through nonlinear dynamics. | 8.18e-06 | 2 | 100 | 2 | 37665666 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 17881658 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 23266958 | ||
| Pubmed | Biliary secretion of alpha-tocopherol and the role of the mdr2 P-glycoprotein in rats and mice. | 8.18e-06 | 2 | 100 | 2 | 9473291 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 10453001 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 2471060 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 10660625 | ||
| Pubmed | Interaction of human organic anion transporters 2 and 4 with organic anion transport inhibitors. | 8.18e-06 | 2 | 100 | 2 | 12023506 | |
| Pubmed | In vitro studies with two human organic anion transporters: OAT2 and OAT7. | 8.18e-06 | 2 | 100 | 2 | 28945155 | |
| Pubmed | Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. | SCAMP4 ATL3 GOLT1B PLXNB2 TRAM1 TMEM30A ATP13A3 ATP2B4 GPR176 | 1.44e-05 | 499 | 100 | 9 | 22810586 |
| Pubmed | 2.09e-05 | 193 | 100 | 6 | 19343046 | ||
| Pubmed | Regulation of biliary lipid secretion by mdr2 P-glycoprotein in the mouse. | 2.45e-05 | 3 | 100 | 2 | 7814632 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 25029804 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 9778357 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 25948251 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 24732756 | ||
| Pubmed | A complex of Neuroplastin and Plasma Membrane Ca2+ ATPase controls T cell activation. | 2.45e-05 | 3 | 100 | 2 | 28827723 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 8547326 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 9542318 | ||
| Interaction | SCN11A interactions | 4.07e-07 | 15 | 86 | 4 | int:SCN11A | |
| Interaction | C2CD4B interactions | 3.68e-05 | 44 | 86 | 4 | int:C2CD4B | |
| Interaction | CCR6 interactions | 3.94e-05 | 89 | 86 | 5 | int:CCR6 | |
| Interaction | LGALS9B interactions | 4.03e-05 | 45 | 86 | 4 | int:LGALS9B | |
| Interaction | SGPP1 interactions | 4.40e-05 | 46 | 86 | 4 | int:SGPP1 | |
| Interaction | SCN5A interactions | 4.79e-05 | 47 | 86 | 4 | int:SCN5A | |
| Interaction | OR2G6 interactions | 5.85e-05 | 18 | 86 | 3 | int:OR2G6 | |
| Cytoband | 12p13.2 | 6.41e-12 | 45 | 97 | 7 | 12p13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12p13 | TAS2R14 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 | 9.00e-07 | 353 | 97 | 8 | chr12p13 |
| Cytoband | 11q13.1 | 3.31e-04 | 63 | 97 | 3 | 11q13.1 | |
| Cytoband | 13q32.3 | 1.09e-03 | 23 | 97 | 2 | 13q32.3 | |
| GeneFamily | Taste 2 receptors | TAS2R14 TAS2R33 TAS2R36 TAS2R45 TAS2R31 TAS2R43 TAS2R20 TAS2R19 TAS2R30 TAS2R46 TAS2R50 | 1.09e-17 | 39 | 81 | 11 | 1162 |
| GeneFamily | Solute carriers | SLC12A6 SLC36A4 SLC2A7 SLC22A11 SLC19A2 FLVCR2 SLC13A2 SLC1A6 SLC22A7 SLC39A8 SLC22A9 SLC15A1 SLC15A2 SLC26A7 SLC47A1 SLC25A29 SLC41A1 SLC7A10 | 1.14e-13 | 395 | 81 | 18 | 752 |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 4.63e-08 | 9 | 81 | 4 | 1203 | |
| GeneFamily | ATPases Ca2+ transporting | 6.99e-04 | 9 | 81 | 2 | 1209 | |
| GeneFamily | ATP binding cassette subfamily B | 1.06e-03 | 11 | 81 | 2 | 806 | |
| GeneFamily | CD molecules|Tetraspanins | 9.57e-03 | 33 | 81 | 2 | 768 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_top-relative-expression-ranked_1000 | CHST9 CELSR1 PANK2 P2RX7 NALCN SLC26A7 SCN7A SCN8A SEL1L3 SLC47A1 ATP13A3 TMEM26 CX3CR1 | 1.57e-05 | 836 | 81 | 13 | gudmap_developingKidney_e15.5_Podocyte cells_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_top-relative-expression-ranked_1000 | SLC19A2 MFSD6L FLVCR2 RASSF7 SLC39A8 EFR3A FAT2 SLC15A2 PROM2 SCN8A SLC47A1 ATP13A3 | 4.02e-05 | 784 | 81 | 12 | gudmap_developingLowerUrinaryTract_e15.5_urothelium_1000 |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-07 | 182 | 97 | 7 | 4a9c13932e7163fd37a3dcc4c6ca3bbea5372459 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-07 | 184 | 97 | 7 | 9434731f651820b05335085582960f08fbf895de | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.67e-07 | 185 | 97 | 7 | 241ea1e178fffef9e7df971de739e794332d5173 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.15e-07 | 192 | 97 | 7 | d3634574b2e8d2ded6446969361b70761b331aea | |
| ToppCell | COVID-19-lung-Secretory|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.15e-07 | 192 | 97 | 7 | 59261098ccb52306f837f632ebaea45b90ad30fe | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.19e-06 | 173 | 97 | 6 | 7dc988fc0ba29990567bf1bcdeb3faeeee507eb1 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.85e-06 | 181 | 97 | 6 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.03e-06 | 183 | 97 | 6 | d73cac83cde82665f110baad7cf28db75f9ffe52 | |
| ToppCell | facs-Trachea-3m-Epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.65e-06 | 189 | 97 | 6 | f8959cc2c14899c8dfeb1b5e51e187537df2f03e | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 3.65e-06 | 189 | 97 | 6 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-06 | 192 | 97 | 6 | 261211a86e6f63b09c2ddce1d2d9257d311f1770 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.00e-06 | 192 | 97 | 6 | 3e1a4cb0d83efd502c8613d41a1692bdda5860ed | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 4.63e-06 | 197 | 97 | 6 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.77e-06 | 198 | 97 | 6 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.05e-06 | 200 | 97 | 6 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-05 | 137 | 97 | 5 | 0aa4e14b32da0cda677cc0ed6ae470f6ecd77bea | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-interstitial_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.53e-05 | 170 | 97 | 5 | f664c7559e383b37845c123e41a3be316d869ba0 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l12|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.53e-05 | 170 | 97 | 5 | 0272eb1487c2545d4aa06f5d1cd77f823e1441e9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.06e-05 | 175 | 97 | 5 | 284fdc7a9d303636a637041846850d19d114861a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.28e-05 | 177 | 97 | 5 | 2f81b26be89cc2fd8eafadaf7eae3c6ad6521462 | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.64e-05 | 180 | 97 | 5 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | COVID-19-kidney-tDL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.64e-05 | 180 | 97 | 5 | 864c895b5eaedefae86f5829fa344f7b686fb59f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.76e-05 | 181 | 97 | 5 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | COVID-19-kidney-Stressed_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.76e-05 | 181 | 97 | 5 | 6980ea624151da32b7f537f263e40fcb87a02e81 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.89e-05 | 182 | 97 | 5 | e1e58176f533092b6b974ca1ce8b02192a6e193d | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT1-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.89e-05 | 182 | 97 | 5 | a95956ce4adccb34cc0c47ebfa1878ce4617904e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.89e-05 | 182 | 97 | 5 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.89e-05 | 182 | 97 | 5 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.89e-05 | 182 | 97 | 5 | 57bb5a2da976464ba7c4460106bd9f692008ebd9 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.02e-05 | 183 | 97 | 5 | 3427f3cbe6ea81709750e7dd3ff378f03ae65eab | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_trachea|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.15e-05 | 184 | 97 | 5 | 45ff845ceed5960a997545c1009012b65e377d50 | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-respiratory_basal_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.15e-05 | 184 | 97 | 5 | 2cc2646dee3c6001f7c10b7449c17d1935021958 | |
| ToppCell | E12.5-Endothelial-capillary_endothelial_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.28e-05 | 185 | 97 | 5 | e005d3c01a908157f780bbc1d53dd2ed814a39d2 | |
| ToppCell | E12.5-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.28e-05 | 185 | 97 | 5 | 0bccc424d0466f7f82baa00127c733640a2d50fb | |
| ToppCell | Control-Epithelial_alveolar|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.28e-05 | 185 | 97 | 5 | 3937e026add96a396122139daf8011cfbc60e75c | |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.28e-05 | 185 | 97 | 5 | 1bbc2ba8a20f72f61981b1301cdd6018cdd9150d | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_2-Mgp-Endothelial_Tip.Dcn.Mgp-Penk_(Penk)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.33e-05 | 94 | 97 | 4 | 8fb9adf0db3b0007204716869d895700cbdc6231 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.42e-05 | 186 | 97 | 5 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.42e-05 | 186 | 97 | 5 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.42e-05 | 186 | 97 | 5 | ac6e32cf07f0f013101ca7aedae0c562857f182b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.42e-05 | 186 | 97 | 5 | a417e1e21313a7e05951038cdef5ac672a9f727c | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.42e-05 | 186 | 97 | 5 | 7cdcf507a9a1349ed2cf62b79116367c3fc732dd | |
| ToppCell | COVID-19-kidney-tDL|kidney / Disease (COVID-19 only), tissue and cell type | 5.56e-05 | 187 | 97 | 5 | d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-05 | 187 | 97 | 5 | dceca7ae3dae96078cccc17a0d8a61b06fa6dffb | |
| ToppCell | P03-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.56e-05 | 187 | 97 | 5 | 66ebe1788d51b3e17bec6cdb219f709756b4e530 | |
| ToppCell | COVID-19-kidney-Stressed_PCT|kidney / Disease (COVID-19 only), tissue and cell type | 5.56e-05 | 187 | 97 | 5 | acd305475f3609800af0d7bc68d83ef41228080b | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____podocyte-2|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.70e-05 | 188 | 97 | 5 | c300accbac71a3bc075fe985543d8a8ead82531b | |
| ToppCell | droplet-Lung-nan-18m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.85e-05 | 189 | 97 | 5 | ca657353f2b649530809c0bc057e448adc511ec1 | |
| ToppCell | droplet-Lung-nan-18m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.85e-05 | 189 | 97 | 5 | e5325f1c7430b574947f8ee67e425455b60dc518 | |
| ToppCell | Adult-Epithelial-club_cell|Adult / Lineage, Cell type, age group and donor | 5.99e-05 | 190 | 97 | 5 | 756bff697d30aec56c0ebfca94295f084a15bf37 | |
| ToppCell | droplet-Trachea-3m-Epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.99e-05 | 190 | 97 | 5 | 0114cf48612d78c3ada4d8a05850501fef6892c5 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_neuroendo|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.99e-05 | 190 | 97 | 5 | 2375e604eacd38f61f3e661ba2f76d286fcceca7 | |
| ToppCell | droplet-Trachea-3m-Epithelial-airway_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.99e-05 | 190 | 97 | 5 | 01e7747547ea1f3049a11a1717565ba71dd52bdc | |
| ToppCell | droplet-Trachea-nan-3m-Epithelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.99e-05 | 190 | 97 | 5 | e647f9a2dcf7f2dffef53c45bbe171416518fd59 | |
| ToppCell | COVID_vent-Lymphocytic-B_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 5.99e-05 | 190 | 97 | 5 | 40b5e9e8f8fd8d84cb5b43e67b49267082348e9f | |
| ToppCell | COVID_vent-Lymphocytic-B_cell-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 5.99e-05 | 190 | 97 | 5 | a37a32dc1b931562a6660074e19d5598efc65284 | |
| ToppCell | droplet-Trachea-nan-3m-Epithelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.99e-05 | 190 | 97 | 5 | 434de72dde09644efbddcaa643a4a3eaf5f643bf | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.15e-05 | 191 | 97 | 5 | 0b296404ebad0aadb75737f8c0462ec6934fc8bb | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 6.30e-05 | 192 | 97 | 5 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.30e-05 | 192 | 97 | 5 | b7c01e12b3e9be960a741b08835f1dfff65d0d47 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating1_(8)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.30e-05 | 192 | 97 | 5 | 8898332387e5d746feb346ce1dabd6b2218fc6e5 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.30e-05 | 192 | 97 | 5 | 1aa5e4d9b32013a3f272561dcb8377f6805706df | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.46e-05 | 193 | 97 | 5 | ffa1932da2979d7b63dbac32eb5788346a3f5b2a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.46e-05 | 193 | 97 | 5 | b93f6af5999ad207fef5edc2bd900c7c6342f626 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_proliferating|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.46e-05 | 193 | 97 | 5 | 5f0eba7b1440beb891d94a288f7f18a4e13c3a88 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^medium_distal_(2)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.46e-05 | 193 | 97 | 5 | 4b8202fcfe639a73f69a13f48fc3601ade256346 | |
| ToppCell | facs-Trachea-nan-3m-Epithelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.61e-05 | 194 | 97 | 5 | 3701ca87c6dc9ccd7b4146e56371546174d26c36 | |
| ToppCell | facs-Trachea-nan-3m-Epithelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.61e-05 | 194 | 97 | 5 | 65f9bf126be26114c2c3f4c46d48318986212a92 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.61e-05 | 194 | 97 | 5 | b30379f8dc41c86c746af9930541fbb4819d8fa0 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.78e-05 | 195 | 97 | 5 | b78db0d929be6b04055805ea5ffecc56c47ba956 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.78e-05 | 195 | 97 | 5 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.11e-05 | 197 | 97 | 5 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 7.11e-05 | 197 | 97 | 5 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.11e-05 | 197 | 97 | 5 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.28e-05 | 198 | 97 | 5 | 28ada093cec552262731194a04a4b9ff93186c3b | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 7.28e-05 | 198 | 97 | 5 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.46e-05 | 199 | 97 | 5 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.46e-05 | 199 | 97 | 5 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-MUC5AC+_High|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 7.46e-05 | 199 | 97 | 5 | a5240868cea40574ed4ee45eb27a00c1812957ed | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.64e-05 | 200 | 97 | 5 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.64e-05 | 200 | 97 | 5 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.64e-05 | 200 | 97 | 5 | 7c2d499af60654b7b28f172ac2c914ad49fb74b4 | |
| ToppCell | severe-Myeloid-CD14_Monocytes_2|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.64e-05 | 200 | 97 | 5 | 27d51fefe914b90e0a16498c43607d52fd38f53c | |
| ToppCell | Control-Epithelial_alveolar-Mes-Like|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.21e-04 | 116 | 97 | 4 | df7609503782d8d7e4f31ed2a626916e5474d5bc | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_2-Mgp|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.56e-04 | 124 | 97 | 4 | b0ed84522180f8cea541461faf7882c57abf8cd4 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.56e-04 | 124 | 97 | 4 | 231862f849d8ab73c6a44c782d33ef2f07661baf | |
| ToppCell | Control-PLT_5|World / Disease Group and Platelet Clusters | 1.66e-04 | 126 | 97 | 4 | 4ba753c4e83eb1d41964edfa22135e047f06c481 | |
| ToppCell | Control-Epithelial_alveolar-Mes-Like-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.71e-04 | 127 | 97 | 4 | 556aaf88719c83f307fa50dfac151136ed05c8ad | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.04e-04 | 133 | 97 | 4 | 5bf5e654653e2c340891f51e3f2a30441b7b6b2b | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Sphkap-Excitatory_Neuron.Gad1Gad2.Sphkap-Cpne4_(Basomedial_amygdaloid_nucleus_(BMA))|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.22e-04 | 54 | 97 | 3 | 7670a6eb185ae0d8c3c0cb17f8eaa9970355187b | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Sphkap-Excitatory_Neuron.Gad1Gad2.Sphkap-Cpne4_(Basomedial_amygdaloid_nucleus_(BMA))-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.22e-04 | 54 | 97 | 3 | 79f804e73f859c0e8192d9e9e6ee2282f7f1691b | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.23e-04 | 136 | 97 | 4 | 27a41463e6f16deb5b1d4f17fefded9959038c07 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.23e-04 | 136 | 97 | 4 | 82b1d6d839c0d0c68e0960549f688138479defcc | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.23e-04 | 136 | 97 | 4 | 88b5c839d0446c6d6b7e81fc4d48f5e7e96eea11 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-B_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.42e-04 | 139 | 97 | 4 | aefcfda2b2db302ce4b3d2a09f767be0b1c3ac6c | |
| ToppCell | 356C-Epithelial_cells-Epithelial-B_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.42e-04 | 139 | 97 | 4 | b9c2dfab119ac0efdf931bb2910e82bccdb4e48d | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Sphkap|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.48e-04 | 56 | 97 | 3 | af55596513ddbe60b08648b27e41a7b65e3da58c | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-04 | 145 | 97 | 4 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Akr1c18_Ntf3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.15e-04 | 149 | 97 | 4 | 1e77f03d2b32f366018fec3462d1b75f6e7febb9 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.48e-04 | 153 | 97 | 4 | 151c469b26f9adf04dd6f117f03bef760cc3d45d | |
| Drug | sodium | SLC12A6 NR2C2 SLC2A7 SLC19A2 SLC13A2 SLC1A6 ADCY8 P2RX7 SLC15A1 SLC15A2 SLC26A7 SCN4A SCN7A SCN10A SLC47A1 ATP2B1 SLC7A10 ATP2B4 | 1.00e-07 | 944 | 98 | 18 | CID000000923 |
| Drug | probenecid | 1.04e-06 | 123 | 98 | 7 | CID000004911 | |
| Drug | APETx1, Anthopleura elegantissima | 1.53e-06 | 6 | 98 | 3 | ctd:C475726 | |
| Drug | AC1NSKPI | 4.67e-06 | 57 | 98 | 5 | CID005311482 | |
| Drug | methylglucamine | 7.10e-06 | 62 | 98 | 5 | CID000004049 | |
| Drug | AC1L1E7E | 9.08e-06 | 10 | 98 | 3 | CID000002673 | |
| Drug | AC1O46SI | 9.08e-06 | 10 | 98 | 3 | CID006400580 | |
| Drug | lamotrigine | 1.10e-05 | 116 | 98 | 6 | CID000003878 | |
| Drug | strontium | 1.12e-05 | 68 | 98 | 5 | CID000104798 | |
| Drug | NSC 117356 | 1.13e-05 | 246 | 98 | 8 | CID000004112 | |
| Drug | cimetidine | 1.25e-05 | 179 | 98 | 7 | CID000002756 | |
| Drug | 5-hydroxypropafenone | 1.36e-05 | 34 | 98 | 4 | CID000107927 | |
| Drug | fluo-3 | 1.47e-05 | 122 | 98 | 6 | CID000104978 | |
| Drug | bepridil | 1.77e-05 | 126 | 98 | 6 | CID000002351 | |
| Drug | moexipril | 1.83e-05 | 2 | 98 | 2 | ctd:C058302 | |
| Drug | 1,9-dideoxyforskolin | 1.83e-05 | 2 | 98 | 2 | ctd:C047983 | |
| Drug | 4-methylumbelliferyl sulfate | 1.83e-05 | 2 | 98 | 2 | ctd:C019492 | |
| Drug | naphthyl sulfate | 1.83e-05 | 2 | 98 | 2 | ctd:C029092 | |
| Drug | glycylsarcosine | 1.83e-05 | 2 | 98 | 2 | ctd:C004194 | |
| Drug | caloxin 1b1 | 1.83e-05 | 2 | 98 | 2 | ctd:C510327 | |
| Drug | quinaprilat | 1.83e-05 | 2 | 98 | 2 | ctd:C054501 | |
| Drug | dihydropyridine | 2.04e-05 | 193 | 98 | 7 | CID000104822 | |
| Drug | Chlorine | 2.97e-05 | 367 | 98 | 9 | ctd:D002713 | |
| Drug | bumetanide | 3.39e-05 | 209 | 98 | 7 | CID000002471 | |
| Drug | sulfinpyrazone | 3.73e-05 | 87 | 98 | 5 | CID000005342 | |
| Drug | Bumetanide | 4.16e-05 | 16 | 98 | 3 | ctd:D002034 | |
| Drug | phenytoin | 4.56e-05 | 219 | 98 | 7 | CID000001775 | |
| Drug | Bay K 8644 | 4.73e-05 | 150 | 98 | 6 | CID000002303 | |
| Drug | verapamil | CACNA1F ADCY8 ABCB1 ABCB4 ITPR3 SCN4A SCN7A SCN10A ATP2B1 ATP2B4 | 5.02e-05 | 490 | 98 | 10 | CID000002520 |
| Drug | spirapril | 5.49e-05 | 3 | 98 | 2 | ctd:C052555 | |
| Drug | Technetium Tc 99m Sestamibi | 5.49e-05 | 3 | 98 | 2 | ctd:D017256 | |
| Drug | nitrendipine | 6.60e-05 | 98 | 98 | 5 | CID000004507 | |
| Drug | 2-(aminomethyl)pyrrolidine | 7.01e-05 | 161 | 98 | 6 | CID000072032 | |
| Drug | tetraphenylphosphonium | 7.13e-05 | 19 | 98 | 3 | CID000164911 | |
| Drug | diprafenone | 7.13e-05 | 19 | 98 | 3 | CID000071249 | |
| Drug | isradipine | 7.26e-05 | 100 | 98 | 5 | CID000003784 | |
| Drug | tetraethylammonium | 7.31e-05 | 236 | 98 | 7 | CID000005413 | |
| Drug | Soybean Oil | 8.36e-05 | 20 | 98 | 3 | ctd:D013024 | |
| Drug | sulfobromophthalein | 8.36e-05 | 103 | 98 | 5 | CID000005345 | |
| Drug | UTP-NA | 8.39e-05 | 420 | 98 | 9 | CID000001181 | |
| Drug | gabapentin | 9.16e-05 | 169 | 98 | 6 | CID000003446 | |
| Drug | potassium | SLC12A6 CACNA1F GALR1 SLC1A6 ADCY8 ITPR3 P2RX7 SCN4A SCN7A SCN10A ATP2B1 SLC7A10 ATP2B4 CX3CR1 | 1.03e-04 | 1008 | 98 | 14 | CID000000813 |
| Drug | dimethylaminobenzoate | 1.09e-04 | 4 | 98 | 2 | CID012241998 | |
| Drug | APETx2 protein, Anthopleura elegantissima | 1.09e-04 | 4 | 98 | 2 | ctd:C501880 | |
| Drug | cinchonine | 1.09e-04 | 4 | 98 | 2 | ctd:C010086 | |
| Drug | carbamazepine | 1.26e-04 | 179 | 98 | 6 | CID000002554 | |
| Drug | estrone sulfate | 1.29e-04 | 23 | 98 | 3 | ctd:C017296 | |
| Drug | NSC7524 | 1.38e-04 | 182 | 98 | 6 | CID000005657 | |
| Drug | AC1NT1AF | 1.66e-04 | 25 | 98 | 3 | CID005322157 | |
| Drug | AC1L1CQC | 1.79e-04 | 65 | 98 | 4 | CID000002012 | |
| Drug | AC1L2MCS | 1.82e-04 | 5 | 98 | 2 | CID000023441 | |
| Drug | Glutarates | 1.82e-04 | 5 | 98 | 2 | ctd:D005977 | |
| Drug | Pirmenolum | 1.87e-04 | 26 | 98 | 3 | CID000004853 | |
| Drug | resiniferatoxin | 1.90e-04 | 66 | 98 | 4 | CID000104826 | |
| Drug | acyclovir | 2.00e-04 | 124 | 98 | 5 | CID000002022 | |
| Drug | PbTx-1 | 2.10e-04 | 27 | 98 | 3 | CID006437089 | |
| Drug | Sulfobromophthalein | 2.10e-04 | 27 | 98 | 3 | ctd:D013448 | |
| Drug | AC1L1MOZ | 2.10e-04 | 27 | 98 | 3 | CID000031958 | |
| Drug | nefopam | 2.10e-04 | 27 | 98 | 3 | CID000004450 | |
| Drug | Pregnenolone [145-13-1]; Up 200; 12.6uM; PC3; HT_HG-U133A | 2.17e-04 | 198 | 98 | 6 | 4218_UP | |
| Drug | prochlorperazine dimaleate salt; Down 200; 10uM; MCF7; HG-U133A | 2.23e-04 | 199 | 98 | 6 | 455_DN | |
| Drug | paraben | 2.34e-04 | 28 | 98 | 3 | CID000007175 | |
| Drug | AC1L1E6T | 2.34e-04 | 28 | 98 | 3 | CID000002666 | |
| Drug | Dehydroepiandrosterone Sulfate | 2.60e-04 | 29 | 98 | 3 | ctd:D019314 | |
| Drug | AC1L1TSE | 2.65e-04 | 72 | 98 | 4 | CID000060719 | |
| Drug | PIHCA | 2.72e-04 | 6 | 98 | 2 | CID000108097 | |
| Drug | v 104 | 2.72e-04 | 6 | 98 | 2 | CID000107262 | |
| Drug | AC1L99H3 | 2.72e-04 | 6 | 98 | 2 | CID000440540 | |
| Drug | tocainide | 2.89e-04 | 30 | 98 | 3 | CID000038945 | |
| Drug | 1, 3-diallylurea | 2.95e-04 | 74 | 98 | 4 | CID000074537 | |
| Drug | sodium bicarbonate | 2.95e-04 | 74 | 98 | 4 | CID000010340 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 5.87e-11 | 10 | 90 | 5 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 5.87e-11 | 10 | 90 | 5 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.84e-10 | 12 | 90 | 5 | DOID:0060170 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 1.85e-09 | 163 | 90 | 9 | DOID:1826 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease (is_implicated_in) | 5.92e-06 | 12 | 90 | 3 | DOID:10595 (is_implicated_in) | |
| Disease | sensory perception of bitter taste | 6.78e-05 | 26 | 90 | 3 | GO_0050913 | |
| Disease | Hailey-Hailey disease (implicated_via_orthology) | 1.37e-04 | 6 | 90 | 2 | DOID:0050429 (implicated_via_orthology) | |
| Disease | gallbladder neoplasm | 3.27e-04 | 9 | 90 | 2 | EFO_0004606 | |
| Disease | cystic fibrosis (implicated_via_orthology) | 3.27e-04 | 9 | 90 | 2 | DOID:1485 (implicated_via_orthology) | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 3.27e-04 | 9 | 90 | 2 | C3502809 | |
| Disease | Intrahepatic cholestasis of pregnancy | 1.07e-03 | 16 | 90 | 2 | EFO_0009048 | |
| Disease | Drug-induced agranulocytosis | 1.07e-03 | 16 | 90 | 2 | HP_0012235 | |
| Disease | theta wave measurement | 1.21e-03 | 17 | 90 | 2 | EFO_0006873 | |
| Disease | Alzheimer disease, brain volume measurement | 1.21e-03 | 17 | 90 | 2 | EFO_0006930, MONDO_0004975 | |
| Disease | Epilepsy, Cryptogenic | 2.04e-03 | 82 | 90 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 2.04e-03 | 82 | 90 | 3 | C0751111 | |
| Disease | Aura | 2.04e-03 | 82 | 90 | 3 | C0236018 | |
| Disease | thalamus volume | 2.26e-03 | 85 | 90 | 3 | EFO_0006935 | |
| Disease | visuospatial function measurement | 2.85e-03 | 26 | 90 | 2 | EFO_0803533 | |
| Disease | pseudotumor cerebri | 2.85e-03 | 26 | 90 | 2 | EFO_1001132 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HFLQGSITFIIGILQ | 521 | Q0P6H9 | |
| SITFIIGILQLAFFN | 526 | Q0P6H9 | |
| NVIIFASILINFLGA | 786 | P40145 | |
| QAFSLGIGICFIELQ | 426 | Q8WWN8 | |
| IIGVGLLQIFQGHFE | 201 | Q9NS82 | |
| LSQIIICIGFQSLGF | 1011 | Q9H7F0 | |
| ITNFTILRQQGVFGD | 1266 | Q8WXG9 | |
| IFAIGLVGNLLVVFA | 41 | P49238 | |
| LFLSQLVFVIGINQT | 2511 | Q9NYQ6 | |
| KIVQNAIIQTIGFFG | 376 | Q14156 | |
| EGIFNNAIFCTIVLG | 1001 | P20020 | |
| VLGTFICQIFIVEFG | 1001 | P23634 | |
| ALAQAIGQTGRFVLV | 36 | Q02833 | |
| LTIVISGHFFIFQGQ | 66 | Q7Z4M0 | |
| NITEELFFTGLIGNV | 556 | P49116 | |
| TNKIVFVVSFVGNRG | 2291 | Q14573 | |
| FVVGVFCAIINGGLQ | 711 | P08183 | |
| VIFGSFFVLNLVLGV | 356 | O60840 | |
| IFVGFVIITFRAQGE | 1131 | O60840 | |
| AGQLFSGLLALNVVF | 86 | Q7RTS5 | |
| QGNQTTITEFILLGF | 16 | Q8NH92 | |
| TRLNQVVLFAGSAFI | 191 | Q8NGT7 | |
| LFIRQGTGLQGQAVF | 471 | Q8WVC0 | |
| AIGNVLFVAGLAFVI | 36 | Q9Y3E0 | |
| IFAIGVGQVDFNTLK | 191 | O00339 | |
| TVQVVIFIGSLLGNF | 46 | Q14439 | |
| VIVGVFLAQIFSLQA | 176 | Q6PXP3 | |
| GAFVGASLLFLLVNV | 141 | Q96N19 | |
| LIDSVLQGFNGTVFA | 81 | O14782 | |
| VLVGAIVSTVQNFLF | 376 | Q8IWD5 | |
| INVTGQGFSLIQRFA | 1001 | O15031 | |
| GFFNINALLGIITLA | 1601 | Q9NYQ8 | |
| LGFVHGGIQTLFIAQ | 146 | A6NMZ5 | |
| AQIGIVAVVRGSLFF | 141 | Q9H255 | |
| TKFNIQGLVIIGGFE | 486 | P08237 | |
| QASVGGQVFILNILF | 191 | Q6U736 | |
| LAIGITANFVNGRTV | 236 | Q8TDZ2 | |
| AQNIANLGTGIIISF | 836 | P21439 | |
| GFGNSFVQVVLTVQL | 156 | Q5JQS5 | |
| QVVFVGNFLRINTIA | 516 | Q9BZ23 | |
| VFGTGGKFDIIQLVV | 321 | Q99572 | |
| LFGIGVENFVTLVVF | 26 | P47211 | |
| NLAVANTGILVFQGF | 241 | Q9Y4F1 | |
| ISGGIFLFFVANAII | 41 | P31358 | |
| INALGLVVFSVAFGL | 266 | P48664 | |
| TGFIGLEVVAQLFNC | 461 | Q6DD88 | |
| FIPIGIGIFVTSNNI | 61 | Q9NV96 | |
| LLNISAQVFGIIFTI | 441 | Q9UPI3 | |
| AQVFGIIFTISQGQI | 446 | Q9UPI3 | |
| LSVGVNFGLFLNIIR | 291 | Q02643 | |
| FINALVFGVQGNTLR | 71 | Q8N8R3 | |
| IQVVIVFAGFLLQGA | 206 | Q7Z601 | |
| VFAGFLLQGAVLARQ | 211 | Q7Z601 | |
| ALVFFVIFLIVQTGN | 76 | Q8N8F7 | |
| LGLNVYQTQLLFGAV | 371 | Q9Y694 | |
| GGVGLFQTLQVLTFI | 11 | Q9NSA0 | |
| VVGTAGVLQAFAIVL | 211 | Q9UHW9 | |
| SNLLFFGGLLVAIAV | 86 | Q13183 | |
| IIVLIVAGAGQFSKQ | 631 | P46059 | |
| GNIIVLVVAQFSGLV | 656 | Q16348 | |
| ALVFGVNTFIALALQ | 421 | O60779 | |
| IFGAQFVLTVIQAIG | 111 | Q969E2 | |
| FVLIVEFIIGNLGNS | 11 | Q9NYV8 | |
| EFIIGNLGNSFIALV | 16 | Q9NYV8 | |
| ILVVFAFVLGNVANG | 11 | P59542 | |
| AFVLGNVANGFIALV | 16 | P59542 | |
| ILVVVAFILGNFANG | 11 | P59543 | |
| ILIVVIFVIGNFANG | 11 | P59541 | |
| IFVIGNFANGFIALV | 16 | P59541 | |
| SVVVVLFVIGNFANG | 11 | P59538 | |
| LFVIGNFANGFIALV | 16 | P59538 | |
| ILVVFAFVLGNFSNG | 11 | P0DSN6 | |
| ILVVFAFVLGNFSNG | 11 | P0DTE0 | |
| SLVVVTFVIGNFANG | 11 | P59537 | |
| TFVIGNFANGFIALV | 16 | P59537 | |
| ILVVVTFVIGNFANG | 11 | P59539 | |
| TFVIGNFANGFIALV | 16 | P59539 | |
| ILIVVTFVIGNFANG | 11 | P59540 | |
| TFVIGNFANGFIALV | 16 | P59540 | |
| LFVLGNFANGFIALV | 16 | P59544 | |
| QFVFALAGIVTNVAA | 181 | O75031 | |
| AALQGFQTQVLGFIE | 276 | Q96LD4 | |
| FRLDISFNGGQIVVT | 356 | Q68CR1 | |
| NIGISVFIQDGPFLV | 256 | Q6ZUK4 | |
| FDNVLTVGNLVFTGI | 606 | P35499 | |
| FGSFLGIIGINLVEN | 66 | Q8WV15 | |
| VTFKDNFRQGLVVGI | 71 | Q9BRQ8 | |
| GNNVFLLQTLFGAVI | 376 | Q8IVM8 | |
| LVFAVTFVLGVLGNG | 31 | P21462 | |
| ALIQVQATVVGFLAS | 181 | Q8IVJ1 | |
| TVFQAVCFLGFIIQL | 446 | Q96FL8 | |
| FNNVLTVGNLVFTGI | 796 | P35498 | |
| KQVFLSVLIFGVAGL | 11 | Q7L1S5 | |
| LIGGILNFQFLRAVT | 86 | Q5HYL7 | |
| LAGSNIFTIGVQDFV | 571 | Q7Z392 | |
| LVGFVFVVSGLVINF | 16 | Q9NRZ7 | |
| FVVSGLVINFVQLCT | 21 | Q9NRZ7 | |
| LVFATFLVGGNVQTL | 491 | Q8N271 | |
| GFFTLNLFVGVIIDN | 1406 | Q9Y5Y9 | |
| FEHVLAVGNLVFTGI | 781 | Q9UQD0 | |
| VFLVFLNGNILGVIR | 536 | Q9NW08 | |
| FSTGNFNVLAVRIAV | 286 | Q15629 | |
| VGLAIGTLFSNAIFQ | 166 | Q9C0K1 | |
| LLNIGNLVFIGIFTA | 536 | Q01118 | |
| VAGVFIAISLLQIFG | 236 | Q8NG11 | |
| FVAQVLVGKFTEGNI | 841 | Q7Z2W4 | |
| FAANVGLLFGVVCTI | 451 | Q8TE54 | |
| IGINFGLLTSEVFQV | 216 | P0C672 | |
| LKNISIAFTGVVGFL | 451 | Q6YBV0 | |
| DPTLFQVVVGILGNF | 91 | Q8NFZ6 | |
| VIGSIFNITGIAINR | 111 | P48039 | |
| IGLTLFVGVVIANFN | 1146 | Q8IZF0 |